EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 30 / No 1 (Janvier 2014) Med Sci (Paris), 30 1 (2014) 9-12 References
Free Access
Issue
Med Sci (Paris)
Volume 30, Number 1, Janvier 2014
Page(s) 9 - 12
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20143001002
Published online 24 January 2014
  1. Rekand T, Gronning M. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up. J Rehabil Med 2011 ; 43 : 511–514. [CrossRef] [PubMed] [Google Scholar]
  2. Gorsane MA, Kebir O, Hache G, et al. Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates. Subst Abus 2012 ; 33: 336–349. [CrossRef] [PubMed] [Google Scholar]
  3. Addolorato G, Leggio L, Agabio R, et al. Baclofen: a new drug for the treatment of alcohol dependence. Int J Clin Pract 2006 ; 60 : 1003–1008. [CrossRef] [PubMed] [Google Scholar]
  4. Bowery NG. GABAB receptor pharmacology. Annu Rev Pharmacol Toxicol 1993 ; 33 : 109–147. [CrossRef] [PubMed] [Google Scholar]
  5. Froestl, W. Chemistry and pharmacology of GABAB receptor ligands. Adv Pharmacol 2010 ; 58 : 19–62. [CrossRef] [PubMed] [Google Scholar]
  6. Guyon A, Kussrow A, Olmsted IR, et al. Baclofen and other GABAB receptor agents are allosteric modulators of the CXCL12 chemokine receptor CXCR4. J Neurosci 2013 ; 33 : 11643–11654. [CrossRef] [PubMed] [Google Scholar]
  7. Banisadr G, Rostene W, Kitabgi P, Parsadaniantz S. Chemokines and brain functions. Curr Drug Targets Inflamm Allergy 2005 ; 4 : 387–399. [CrossRef] [PubMed] [Google Scholar]
  8. Guyon A, Massa F, Rovere C, Nahon JL. How cytokines can influence the brain: a role for chemokines? J Neuroimmunol 2008 ; 198 : 46–55. [CrossRef] [PubMed] [Google Scholar]
  9. Toth PT, Ren D, Miller RJ. Regulation of CXCR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study. J Pharmacol Exp Ther 2004 ; 310 : 8–17. [CrossRef] [PubMed] [Google Scholar]
  10. Ortega A. A new role for GABA: inhibition of tumor cell migration. Trends Pharmacol Sci 2003 ; 24 : 151–154. [CrossRef] [PubMed] [Google Scholar]
  11. Guyon A, Skrzydelski D, Rovère C, et al. Stromal-cell-derived factor 1alpha /CXCL12 modulates high-threshold calcium currents in rat substantia nigra. Eur J Neurosci 2008 ; 28 : 862–870. [CrossRef] [PubMed] [Google Scholar]
  12. Pello OM, Martínez-Muñoz L, Parrillas V, et al. Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation. Eur J Immunol 2008 ; 38 : 537–549. [CrossRef] [PubMed] [Google Scholar]
  13. Sohy D, Parmentier M, Springael JY. Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. J Biol Chem 2007 ; 282 : 30062–30069. [CrossRef] [PubMed] [Google Scholar]
  14. Percherancier Y, Berchiche YA, Slight I, et al. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J Biol Chem 2005 ; 280 : 9895–9903. [CrossRef] [PubMed] [Google Scholar]
  15. Babcock GJ, Farzan M, Sodroski J. Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J Biol Chem 2003 ; 278 : 3378–3385. [CrossRef] [PubMed] [Google Scholar]
  16. Baksh MM, Kussrow AK, Mileni M, et al. Label-free quantification of membrane-ligand interactions using backscattering interferometry. Nat Biotechnol 2011 ; 29 : 357–360. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.